7 Healthtech E&O Mistakes CT Startups Make (And What Each One Costs)

At iConn Insurance Solutions, we work with CT healthtech founders from pre-seed pure-SaaS shops in New Haven all the way up to Series B telehealth platforms operating across 30 states. The mistakes we see repeat themselves with remarkable consistency — and each one shows up at the worst possible moment, after the OCR letter has been opened or after a clinician partner has been served with a malpractice complaint that names your software.

Below is the working list we walk through with every healthtech client during their first coverage review. Seven mistakes. What each one is. What it costs to fix today. What it costs when an HHS OCR investigator or plaintiff's attorney is on the other end of the phone instead.

Mistake #1: Assuming Tech E&O Alone Covers HIPAA

The first and most common mistake: a healthtech founder buys a generic Tech E&O policy from a startup-focused carrier, sees the word "privacy" mentioned somewhere in the form, and assumes HIPAA is covered. It usually isn't — at least not in the way that matters.

A real healthtech E&O stack needs three things explicitly:

• HIPAA regulatory defense — defense costs and civil penalties from an HHS OCR investigation
• PHI breach response — forensics, notification (sub-500 + 500+), credit monitoring, crisis PR
• Privacy liability — third-party suits arising from a PHI exposure (class action ready)

Generic Tech E&O written for SaaS may cover only the first half of the third bullet. The other coverage layers have to be explicitly endorsed or written through a healthtech-fluent carrier.

Cost to fix in advance: $2K-$5K of additional premium per year to add proper HIPAA regulatory defense and full PHI breach response.

Cost when an OCR letter arrives: $75K-$400K in regulatory defense and civil penalties for a typical mid-sized CT healthtech breach. Plus the credit monitoring and notification costs of $30-$100 per affected record. Math gets ugly fast.

Mistake #2: Buying Cyber Without HIPAA-Specific Defense Wording

A close cousin of #1. The founder this time does buy Cyber — but it's an off-the-shelf SMB cyber policy that has generic privacy regulatory defense, not HIPAA-specific defense. There's a real difference.

A HIPAA-specific defense form will:

• Name HHS OCR explicitly as a covered regulator
• Cover defense for Business Associate Agreement violations
• Cover defense for State AG actions tied to HIPAA
• Provide panel counsel with documented healthcare regulatory experience
• Cover the cost of resolution agreements and corrective action plans

Most generic cyber forms only cover state breach notification laws. They go silent or actively exclude HHS proceedings — exactly the proceeding that costs CT healthtechs the most.

Cost to fix in advance: Often $0 — the right carrier just writes the right form. The expensive version is buying twice because the first form didn't fit.

Cost when HHS opens an investigation: $100K-$500K in legal defense fees on top of any penalties. We've seen CT healthtechs absorb defense bills alone north of $300K before settlement.

Mistake #3: Ignoring Whether You Need Medical Malpractice

Founders running pure-SaaS healthtech platforms often dismiss Medical Malpractice ("Med Mal") immediately. "We're not clinicians." Fair. But the question isn't whether you employ clinicians — it's whether the software directly influences clinical decisions, dosing, diagnosis, or triage.

If your platform does any of the following, you likely need Med Mal or a hybrid Tech E&O / Med Mal form:

• Provides clinical decision support (CDS) outputs to a clinician
• Runs algorithms that triage symptoms or recommend follow-up
• Dispenses or routes telehealth visits
• Manages chronic-condition care plans
• Employs or contracts clinicians who deliver care through your platform
• Manufactures or distributes Software-as-a-Medical-Device (SaMD)

The trickiest gap: contracted clinicians. Most carriers require the clinicians themselves to carry primary Med Mal, but your platform also needs a layer to absorb the indirect-liability suit that names your software when a clinician's care decision goes sideways.

Cost to fix in advance: $5K-$25K/year for a hybrid Tech E&O / Med Mal endorsement on a Series A telehealth platform of typical size.

Cost when a malpractice claim names your platform: $200K-$2M+ in defense and indemnity exposure on a single clinical-outcome suit. Plaintiff's attorneys now routinely add the software vendor as a named co-defendant — by design.

Mistake #4: Under-Insuring Against PHI Breach Math

A healthtech breach is not priced like a generic data breach. The cost-per-record on PHI is materially higher than on credentials or financial data, and OCR penalty math compounds on top of state breach laws and class-action exposure.

Typical 2026 PHI breach cost components for a CT healthtech:

• Forensics + IR: $50K-$150K
• Notification: $5-$15/record for sub-500; $20-$60/record for 500+ with HHS reporting
• Credit + medical monitoring: $30-$120/record/year, typically 1-2 years
• OCR civil penalties: $0 to $2M+ depending on culpability tier
• State AG action: $50K-$500K range typical
• Class action defense + settlement: $250K-$5M+ depending on record count and harm allegations

A founder who buys $1M of combined Cyber + E&O limits to cover a 50,000-PHI-record platform is dramatically under-insured. The math says you need $3M-$10M just to absorb a mid-grade incident, not a worst-case one. See the HHS OCR enforcement portal at hhs.gov/hipaa for live examples of how the math has played out.

Cost to fix in advance: $3K-$15K/year of additional premium to right-size limits.

Cost when limits run out: The remainder comes from the company balance sheet. We have seen one CT healthtech go from "well-capitalized post-Series-A" to "emergency bridge round" in the 90 days after a breach because limits were set $2M too low.

Mistake #5: Missing FDA / SaMD Coverage Carve-Outs

If your platform is or might become Software-as-a-Medical-Device under FDA classification (Class I, II, or III), you have an entire second layer of regulatory exposure that generic healthtech E&O doesn't touch.

A SaMD-aware policy will cover:

• FDA inspection and Form 483 / Warning Letter defense
• Product recall (software de-listing, version rollback, customer notification)
• Bodily injury arising from software malfunction (carved out of generic Tech E&O)
• Quality System Regulation (21 CFR Part 820) violation defense

Most off-the-shelf Tech E&O policies have a hard bodily injury exclusion. For a SaMD product, that single exclusion can swallow the entire reason you bought the policy. The fix is either (a) a properly negotiated bodily-injury carve-back, or (b) layering in dedicated Products / Med Mal coverage.

Cost to fix in advance: $8K-$40K/year of additional premium depending on FDA class and device function.

Cost when bodily injury is alleged: The bodily-injury exclusion bites. Defense + indemnity falls entirely on the company. A single product-liability suit on a misclassified Class II device can run $500K-$5M.

Mistake #6: Leaving AI / Clinical-Decision Exclusions Un-Negotiated

2026 carriers are adding AI-specific exclusions to healthtech E&O policies faster than founders are reading them. If your platform uses ML/AI to assist with diagnosis, triage, dosing, clinical alerts, or risk stratification, the boilerplate AI exclusion can quietly remove your most important coverage.

Watch for exclusions worded like:

• "Any claim arising out of artificial intelligence, machine learning, or algorithmic decision-making"
• "Bodily injury or property damage arising out of automated clinical decision support"
• "Claims arising from the use of large language models or generative AI"

These exclusions are negotiable in 2026 — but only if your broker asks for the carve-back, names the specific AI use cases in the application, and produces an AI governance document showing how the model is trained, validated, monitored, and overridden by clinicians. Founders who skip the negotiation get whatever the boilerplate says.

Cost to fix in advance: 2-4 hours of broker work; sometimes a modest additional premium ($1K-$5K/year) for the carve-back endorsement.

Cost when AI-related claim is denied: Total loss of coverage on whatever claim type is excluded. Increasingly, that's the only kind of claim the company is likely to face — making the rest of the policy nearly worthless.

Mistake #7: Letting the Policy Lapse Mid-Funding or Mid-Pilot

Like the fintech sibling mistake, but with higher stakes — healthtech E&O is claims-made with retroactive coverage, and a single missed renewal during a fundraise or hospital-system pilot reset wipes out trailing exposure from the entire prior policy period.

Cost to fix in advance: $0. Renew on time. Use premium financing if cash is tight.

Cost when the lapse happens: Lost retroactive coverage on potentially the entire trailing year of PHI handling. A breach discovered three months after the lapse, but tied to activity from before, has no policy responding. Six-figure to seven-figure liability with no carrier on the hook.

The Seven Mistakes Side-by-Side

Frequently Asked Questions About Healthtech E&O Mistakes